NCT05647213View on ClinicalTrials.gov

Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease

PHASE1RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 3, 2023

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2029

Conditions
Univentricular HeartCongenital Heart DiseaseHeart Failure NYHA Class IIIHeart Failure NYHA Class IV
Interventions
BIOLOGICAL

iPSC-CL

Autologous IPSCL

Trial Locations (1)

55901

RECRUITING

Mayo Clinic, Rochester

All Listed Sponsors
lead

HeartWorks, Inc.

OTHER